Name: IX BIOPHARMA LTD. Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 41 across all filing types

Latest filing 2026-05-22 Share Issue/Capital Cha…

Country SG Singapore

Listing SGX 42C

About IX BIOPHARMA LTD.

https://www.ixbiopharma.com/

IX Biopharma Ltd. is a specialty pharmaceutical and nutraceutical company focused on developing and commercializing innovative therapies. Leveraging its proprietary WaferiX sublingual drug delivery technology, the company aims to improve the quality of life for patients with pain, chronic diseases, and debilitating conditions, particularly those affecting the central nervous system. A key product is Wafermine, a sublingual ketamine wafer designed for rapid, non-opioid relief of acute moderate to severe pain. The company was recently awarded a US$41 million U.S. government contract to fund Wafermine's Phase 3 clinical development and secure FDA Emergency Use Authorization. Additionally, iX Biopharma offers nutraceutical products, such as a sublingual NAD+ wafer for cellular energy production.

Recent filings

Filing	Released	Lang
Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-05-22	English
Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-05-15	English
Equity Listing - Ordinary Shares::Issue and Allotment of New Shares Pursuant to iX Performance Share Plan Share Issue/Capital Change	2026-05-13	English
Equity Listing - Ordinary Shares::Issuance and Allotment of Directors' Shares and Subscription Shares Share Issue/Capital Change	2026-05-13	English
Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-05-12	English
Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-05-06	English

Browse filings by year

2 years

	ID	Filing	Released	Lang
2026 15 filings
	46792398	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-05-22	English
	46351593	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-05-15	English
	45529702	Equity Listing - Ordinary Shares::Issue and Allotment of New Shares Pursuant to iX Performance Share Plan Share Issue/Capital Change	2026-05-13	English
	45529698	Equity Listing - Ordinary Shares::Issuance and Allotment of Directors' Shares and Subscription Shares Share Issue/Capital Change	2026-05-13	English
	45207125	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-05-12	English
	44887880	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-05-06	English
	44889131	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Share Issue/Capital Change	2026-04-28	English
	44889790	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Regulatory Filings	2026-04-23	English
	44889870	Extraordinary/ Special General Meeting::Voluntary Regulatory Filings	2026-04-23	English
	44887424	REPL::Extraordinary/ Special General Meeting::Voluntary Regulatory Filings	2026-04-23	English
	44890246	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Regulatory Filings	2026-04-17	English
	44890279	General Announcement::Proposed Placement of 1,349,434 New Ordinary Shares to Anson Properties Pte. Ltd. and Directors Regulatory Filings	2026-04-16	English
	44891511	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Regulatory Filings	2026-04-08	English
	44892538	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Regulatory Filings	2026-03-25	English
	44892859	Equity Listing - Ordinary Shares::Issue and Allotment of Shares Pursuant to Exercise of Warrants Regulatory Filings	2026-03-19	English

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
Abliva Biopharmaceutical company developing medicines for primary …	ABLI	SE	Manufacturing
AB Science Researches and develops protein kinase inhibitors for human…	AB	FR	Manufacturing
ABVC BIOPHARMA, INC. Develops botanical drugs and medical devices for oncology, …	ABVC	US	Manufacturing
ACADIA PHARMACEUTICALS INC Biopharmaceutical company developing medicines for CNS diso…	ACAD	US	Manufacturing
Access Bio, Inc. Develops and manufactures in vitro diagnostic solutions for…	950130	IN	Manufacturing
Accretion Nutraveda Limited Develops and manufactures pharmaceutical, nutraceutical, an…	544694	IN	Manufacturing
Accretion Pharmaceuticals Limited Develops and manufactures therapeutic formulations across d…	ACCPL	IN	Manufacturing
Acerus Pharmaceuticals Corporation Specialty pharmaceutical company focused on developing and …	ASPCF	CA	Manufacturing
ACHIEVE LIFE SCIENCES, INC. A late-stage pharmaceutical company developing a treatment …	ACHV	US	Manufacturing
Achyut Healthcare Limited Procures, trades, and manufactures pharmaceutical APIs and …	543499	IN	Manufacturing

Page 4 of 221

Prev … 2 3 4 5 6 … Next

IX BIOPHARMA LTD. via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID67403

Ticker42C

ISINSG1BD9000009

Endpoints

most-used routes for this company

GET	/api/companies/67403/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=67403	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=67403	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for IX BIOPHARMA LTD.

$ curl https://api.financialreports.eu/api/filings/?company=67403 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 67403},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for IX BIOPHARMA LTD. (id: 67403)"

IX BIOPHARMA LTD. — Investor Relations & Filings